QuidelOrtho (QDEL) Securities Investigation Notice - Levi & Korsinsky

详细摘要
QuidelOrtho shares fell roughly 14% after third-quarter 2026 results showed China revenue down 45% and respiratory revenue down 39%. Levi & Korsinsky is investigating on behalf of…
QuidelOrtho shares fell roughly 14% after third-quarter 2026 results showed China revenue down 45% and respiratory revenue down 39%. Levi & Korsinsky is investigating on behalf of investors who lost money.
NEW YORK, Nov. 16, 2026 /PRNewswire/ -- QuidelOrtho Corporation (NASDAQ: QDEL) shares fell approximately 14% after the Company's third-quarter 2026 results showed China revenue down 45% and respiratory revenue down 39%. If you held QDEL when those results were released, the decline may have hit your account directly. Investors who suffered losses are encouraged to submit your loss details now or to contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.
The declines centered on specific parts of the business. According to the Company's earnings materials, the 45% drop in China revenue was tied to distributor destocking and pricing changes. Point-of-Care revenue fell 27% in the same quarter, and total sales fell roughly 12% from the prior-year period.
QuidelOrtho's May 6, 2026 Form 10-Q referenced China's volume-based procurement (VBP) program, a government-led purchasing system for medical products. Levi & Korsinsky is investigating potential securities law violations on behalf of QDEL investors. The investigation focuses on the Company's exposure to China pricing and to demand for respiratory testing.
Lost money on QDEL? Start your no-cost loss review today or call (212) 363-7500.
ABOUT LEVI & KORSINSKY, LLP -- Over the past 20 years, Levi & Korsinsky has secured billions of dollars for aggrieved shareholders. The firm has extensive expertise in complex securities litigation and a team of over 70 employees. For seven consecutive years, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report.
Q: Who is conducting the QDEL investigation? A: Levi & Korsinsky, LLP is investigating potential securities law claims on behalf of investors who purchased QDEL securities.
Q: Who is eligible to participate in the QDEL investigation?
Q: How…
文章开头,摘自PR Newswire。如需阅读全文,请前往媒体网站。
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.prnewswire.com)
